Self-collection of vaginal swabs for human papillomavirus screening among women in temporary residential programs
- PMID: 26723193
- PMCID: PMC4892360
- DOI: 10.1016/j.ajog.2015.12.036
Self-collection of vaginal swabs for human papillomavirus screening among women in temporary residential programs
Conflict of interest statement
The authors report no conflicts of interest.
Similar articles
-
Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.Lancet. 2011 Nov 26;378(9806):1868-73. doi: 10.1016/S0140-6736(11)61522-5. Epub 2011 Nov 1. Lancet. 2011. PMID: 22051739 Clinical Trial.
-
Comparison of non-invasive sampling methods for detection of HPV in rural African women.Sex Transm Infect. 2005 Jun;81(3):239-41. doi: 10.1136/sti.2004.010413. Sex Transm Infect. 2005. PMID: 15923294 Free PMC article.
-
Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.J Womens Health (Larchmt). 2016 May;25(5):489-97. doi: 10.1089/jwh.2015.5348. Epub 2015 Nov 24. J Womens Health (Larchmt). 2016. PMID: 26598955 Clinical Trial.
-
HPV testing. Visible expectations and hidden realities.Am J Clin Pathol. 2003 Oct;120(4):483-4. doi: 10.1309/66UT-87WY-1PUR-3PR8. Am J Clin Pathol. 2003. PMID: 14560559 Review. No abstract available.
-
Primary screening for human papillomavirus infection.Best Pract Res Clin Obstet Gynaecol. 2001 Oct;15(5):743-57. doi: 10.1053/beog.2001.0217. Best Pract Res Clin Obstet Gynaecol. 2001. PMID: 11563870 Review.
Cited by
-
Acute Pancreatitis During and After Pregnancy: Incidence, Risk Factors, and Prognosis.Dig Dis Sci. 2021 Sep;66(9):3164-3170. doi: 10.1007/s10620-020-06608-5. Epub 2020 Oct 21. Dig Dis Sci. 2021. PMID: 33085013
-
Prevalence of vaginal and cervical HPV infection among 35-year age cohort ever-married women in Kalutara district of Sri Lanka and the validity of vaginal HPV/DNA specimen as a cervical cancer screening tool: a cross-sectional study.BMC Infect Dis. 2024 Nov 5;24(1):1249. doi: 10.1186/s12879-024-10150-4. BMC Infect Dis. 2024. PMID: 39501190 Free PMC article.
References
-
- Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008;109(Suppl 2):S22–S30. - PubMed
-
- Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994;272:530–534. - PubMed
-
- Pollack A. FDA Panel recommends replacement for the Pap test. The New York Times; 2014. Mar 12, p. B1.
-
- Arbyn M, Verdoodt F, Snijders PJ, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15:172–183. - PubMed
-
- Huh WK, Ault KA, Chelmow D. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clincial guidance. Gynecol Oncol. 2015;136:178–182. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources